[16 August 2022] SK bioscience announced that Tae Won Chey, Chairman of SK group, Chang Won (Andrew) Chey, Executive Vice Chairman of SK discovery, and Jaeyong (Jay) Ahn, CEO of SK bioscience, met with Bill Gates, co-chair of the Bill & Melinda Gates Foundation, in Yeouido, Seoul, S. Korea on 16 August to discuss shared commitments to global health.

SK bioscience and the Bill & Melinda Gates Foundation have collaborated since 2013, with the foundation funding SK bioscience’s efforts to develop several products, including a typhoid vaccine, non-replicating rotavirus vaccine, COVID-19 vaccine, and an antiviral nasal spray for COVID-19 prevention.

The organizations will continue to explore opportunities for future collaboration to address unmet global health needs and accelerate the R&D of new tools to improve pandemic preparedness and response.